BioCentury
ARTICLE | Clinical News

AIKO-150: Phase I data

October 4, 2010 7:00 AM UTC

A dose-escalating Phase I trial in 5 healthy volunteers administered morphine showed that 1-20 mg doses of AIKO-150 selectively improved bowel motility without interfering with opioid-induced pain rel...